Working… Menu

A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01094496
Recruitment Status : Terminated (Portfolio prioritization due to slow enrollment)
First Posted : March 29, 2010
Last Update Posted : March 15, 2016
Information provided by (Responsible Party):
Celldex Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2011
Estimated Study Completion Date : October 2017
Certification/Extension First Submitted : February 16, 2016